"Cardiomyopathies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Descriptor ID |
D009202
|
| MeSH Number(s) |
C14.280.238
|
| Concept/Terms |
Cardiomyopathies- Cardiomyopathies
- Cardiomyopathy
- Myocardial Diseases
- Disease, Myocardial
- Diseases, Myocardial
- Myocardial Disease
- Myocardiopathies
- Myocardiopathy
Cardiomyopathies, Secondary- Cardiomyopathies, Secondary
- Cardiomyopathy, Secondary
- Secondary Cardiomyopathies
- Secondary Cardiomyopathy
- Secondary Myocardial Diseases
- Disease, Secondary Myocardial
- Diseases, Secondary Myocardial
- Myocardial Disease, Secondary
- Secondary Myocardial Disease
- Myocardial Diseases, Secondary
Cardiomyopathies, Primary- Cardiomyopathies, Primary
- Cardiomyopathy, Primary
- Primary Cardiomyopathies
- Primary Cardiomyopathy
- Primary Myocardial Diseases
- Myocardial Diseases, Primary
- Disease, Primary Myocardial
- Diseases, Primary Myocardial
- Myocardial Disease, Primary
- Primary Myocardial Disease
|
Below are MeSH descriptors whose meaning is more general than "Cardiomyopathies".
Below are MeSH descriptors whose meaning is more specific than "Cardiomyopathies".
This graph shows the total number of publications written about "Cardiomyopathies" by people in this website by year, and whether "Cardiomyopathies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 0 | 1 |
| 1994 | 1 | 0 | 1 |
| 1997 | 1 | 2 | 3 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 1 | 2 |
| 2000 | 2 | 0 | 2 |
| 2001 | 1 | 1 | 2 |
| 2002 | 0 | 2 | 2 |
| 2003 | 2 | 0 | 2 |
| 2004 | 3 | 0 | 3 |
| 2005 | 2 | 1 | 3 |
| 2006 | 2 | 1 | 3 |
| 2007 | 2 | 1 | 3 |
| 2008 | 3 | 0 | 3 |
| 2009 | 3 | 1 | 4 |
| 2010 | 2 | 1 | 3 |
| 2011 | 4 | 2 | 6 |
| 2012 | 3 | 3 | 6 |
| 2013 | 3 | 3 | 6 |
| 2014 | 9 | 1 | 10 |
| 2015 | 2 | 3 | 5 |
| 2016 | 6 | 1 | 7 |
| 2017 | 10 | 2 | 12 |
| 2018 | 11 | 1 | 12 |
| 2019 | 3 | 0 | 3 |
| 2020 | 9 | 2 | 11 |
| 2021 | 5 | 0 | 5 |
| 2022 | 7 | 0 | 7 |
| 2023 | 7 | 0 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cardiomyopathies" by people in Profiles.
-
How Often Does Apical Sparing of Longitudinal Strain Indicate the Presence of Cardiac Amyloidosis? Am J Cardiol. 2023 09 01; 202:12-16.
-
Comparative Analysis of Whole Transcriptome Profiles in Septic Cardiomyopathy: Insights from CLP- and LPS-Induced Mouse Models. Genes (Basel). 2023 06 28; 14(7).
-
Non-invasive diagnosis of transthyretin cardiac amyloidosis utilizing typical late gadolinium enhancement pattern on cardiac magnetic resonance and light chains. Eur Heart J Cardiovasc Imaging. 2023 05 31; 24(6):829-837.
-
A Protocol for Simultaneous In Vivo Imaging of Cardiac and Neuroinflammation in Dystrophin-Deficient MDX Mice Using [18F]FEPPA PET. Int J Mol Sci. 2023 Apr 19; 24(8).
-
Mechanisms of Sarcomere Protein Mutation-Induced Cardiomyopathies. Curr Cardiol Rep. 2023 06; 25(6):473-484.
-
Transcatheter Left Ventricular Restoration in Patients With Heart Failure. J Card Fail. 2023 Jul; 29(7):1046-1055.
-
Serum amyloidosis: a cardiac amyloidosis. Eur Heart J Cardiovasc Imaging. 2023 03 21; 24(4):e59.
-
Impairment in quantitative microvascular function in non-ischemic cardiomyopathy as demonstrated using cardiovascular magnetic resonance. PLoS One. 2022; 17(11):e0264454.
-
99m Technetium-pyrophosphate bone scan: A potential biomarker for the burden of transthyretin amyloidosis in skeletal muscle: A preliminary study. Muscle Nerve. 2023 Feb; 67(2):111-116.
-
Impact of Tafamidis on Survival in a Real-World Community-Based Cohort. Curr Probl Cardiol. 2022 Dec; 47(12):101358.